• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨质疏松症的遗传决定因素:与心血管疾病的共同基础?

Genetic determinants of osteoporosis: common bases to cardiovascular diseases?

作者信息

Marini Francesca, Brandi Maria Luisa

机构信息

Department of Internal Medicine, University of Florence, Viale Pieraccini, 6, 50139 Florence, Italy.

出版信息

Int J Hypertens. 2010 Mar 25;2010:394579. doi: 10.4061/2010/394579.

DOI:10.4061/2010/394579
PMID:20948561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2949079/
Abstract

Osteoporosis is the most common and serious age-related skeletal disorder, characterized by a low bone mass and bone microarchitectural deterioration, with a consequent increase in bone fragility and susceptibility to spontaneous fractures, and it represents a major worldwide health care problem with important implications for health care costs, morbidity and mortality. Today is well accepted that osteoporosis is a multifactorial disorder caused by the interaction between environment and genes that singularly exert modest effects on bone mass and other aspects of bone strength and fracture risk. The individuation of genetic factors responsible for osteoporosis predisposition and development is fundamental for the disease prevention and for the setting of novel therapies, before fracture occurrence. In the last decades the interest of the Scientific Community has been concentrated in the understanding the genetic bases of this disease but with controversial and/or inconclusive results. This review tries to summarize data on the most representative osteoporosis candidate genes. Moreover, since recently osteoporosis and cardiovascular diseases have shown to share common physiopathological mechanisms, this review also provides information on the current understanding of osteoporosis and cardiovascular diseases common genetic bases.

摘要

骨质疏松症是最常见且最严重的与年龄相关的骨骼疾病,其特征为骨量低和骨微结构恶化,进而导致骨脆性增加以及易发生自发性骨折,它是一个全球性的重大医疗保健问题,对医疗成本、发病率和死亡率具有重要影响。如今,人们普遍认为骨质疏松症是一种多因素疾病,由环境与基因之间的相互作用引起,这些因素单独对骨量以及骨强度和骨折风险的其他方面产生适度影响。在骨折发生之前,确定导致骨质疏松症易感性和发展的遗传因素对于疾病预防和新疗法的制定至关重要。在过去几十年中,科学界的兴趣集中在了解该疾病的遗传基础,但结果存在争议和/或尚无定论。本综述试图总结关于最具代表性的骨质疏松症候选基因的数据。此外,由于最近已表明骨质疏松症和心血管疾病具有共同的生理病理机制,本综述还提供了关于目前对骨质疏松症和心血管疾病共同遗传基础的理解的信息。

相似文献

1
Genetic determinants of osteoporosis: common bases to cardiovascular diseases?骨质疏松症的遗传决定因素:与心血管疾病的共同基础?
Int J Hypertens. 2010 Mar 25;2010:394579. doi: 10.4061/2010/394579.
2
Osteoporosis therapies in 2014.2014年的骨质疏松症治疗方法。
Panminerva Med. 2014;56(4):273-83.
3
Molecular and genetic mechanisms of osteoporosis: implication for treatment.骨质疏松症的分子和遗传机制:对治疗的启示
Curr Mol Med. 2003 Dec;3(8):737-57. doi: 10.2174/1566524033479375.
4
Recent progress in understanding the genetic susceptibility to osteoporosis.骨质疏松症遗传易感性认识方面的最新进展。
Genet Epidemiol. 1999;16(4):356-67. doi: 10.1002/(SICI)1098-2272(1999)16:4<356::AID-GEPI3>3.0.CO;2-I.
5
Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms.骨质疏松症的遗传学:类固醇激素受体基因多态性的作用
J Steroid Biochem Mol Biol. 2002 May;81(1):1-24. doi: 10.1016/s0960-0760(02)00043-2.
6
Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.美国医疗保健研究与质量局(AHRQ)对低骨密度或骨质疏松症男性和女性预防骨折治疗的比较效果评价总结:2007年报告更新版
J Manag Care Pharm. 2012 May;18(4 Suppl B):S1-15; discussion S13. doi: 10.18553/jmcp.2012.18.s4-b.1.
7
Prevention and management of osteoporosis.骨质疏松症的预防与管理。
World Health Organ Tech Rep Ser. 2003;921:1-164, back cover.
8
Role of genetic factors in the pathogenesis of osteoporosis.遗传因素在骨质疏松症发病机制中的作用。
J Endocrinol. 2000 Aug;166(2):235-45. doi: 10.1677/joe.0.1660235.
9
The prevention of osteoporosis and sarcopenia in older adults.老年人骨质疏松症和肌肉减少症的预防。
J Am Geriatr Soc. 2021 May;69(5):1388-1398. doi: 10.1111/jgs.17043. Epub 2021 Feb 23.
10

引用本文的文献

1
The association of bone mineral density with cardiovascular disease and mortality among individuals with/without type 2 diabetes: a population-based retrospective cohort.2型糖尿病患者与非2型糖尿病患者的骨矿物质密度与心血管疾病及死亡率的关联:一项基于人群的回顾性队列研究
Diabetol Metab Syndr. 2025 Aug 27;17(1):354. doi: 10.1186/s13098-025-01924-0.
2
Prevalence of osteoporosis and associated factors among people aged 50 years and older in the Madhesh province of Nepal: a community-based cross-sectional study.尼泊尔马德西省 50 岁及以上人群骨质疏松症的患病率及相关因素:一项基于社区的横断面研究。
J Health Popul Nutr. 2024 Jul 4;43(1):100. doi: 10.1186/s41043-024-00591-7.
3
Mesenchymal stem cells: amazing remedies for bone and cartilage defects.间充质干细胞:治疗骨和软骨缺损的神奇方法。
Stem Cell Res Ther. 2020 Nov 23;11(1):492. doi: 10.1186/s13287-020-02001-1.
4
Identification of a Core Module for Bone Mineral Density through the Integration of a Co-expression Network and GWAS Data.通过共表达网络和 GWAS 数据的整合鉴定骨密度的核心模块。
Cell Rep. 2020 Sep 15;32(11):108145. doi: 10.1016/j.celrep.2020.108145.
5
Relationship between the changes over time of bone mass and muscle health in children and adults: a systematic review and meta-analysis.儿童和成人的骨量随时间变化与肌肉健康之间的关系:系统评价和荟萃分析。
BMC Musculoskelet Disord. 2019 Sep 14;20(1):429. doi: 10.1186/s12891-019-2752-4.
6
Genetic sharing with coronary artery disease identifies potential novel loci for bone mineral density.与冠状动脉疾病相关的遗传共享为骨密度的潜在新基因座提供了线索。
Bone. 2017 Oct;103:70-77. doi: 10.1016/j.bone.2017.06.016. Epub 2017 Jun 23.
7
Suppression of Transforming Growth Factor-β Signaling Delays Cellular Senescence and Preserves the Function of Endothelial Cells Derived from Human Pluripotent Stem Cells.抑制转化生长因子-β信号可延缓细胞衰老并维持人多能干细胞来源的内皮细胞的功能。
Stem Cells Transl Med. 2017 Feb;6(2):589-600. doi: 10.5966/sctm.2016-0089. Epub 2016 Sep 20.
8
Genetics of pediatric bone strength.儿童骨强度的遗传学
Bonekey Rep. 2016 Jul 20;5:823. doi: 10.1038/bonekey.2016.50. eCollection 2016.
9
Low bone mineral density is associated with increased arterial stiffness in participants of a health records based study.在一项基于健康记录的研究参与者中,低骨矿物质密度与动脉僵硬度增加有关。
J Thorac Dis. 2015 May;7(5):790-8. doi: 10.3978/j.issn.2072-1439.2015.04.47.
10
CARDIO-PRED: an in silico tool for predicting cardiovascular-disorder associated proteins.CARDIO-PRED:一种用于预测心血管疾病相关蛋白质的计算机模拟工具。
Syst Synth Biol. 2015 Jun;9(1-2):55-66. doi: 10.1007/s11693-015-9164-z. Epub 2015 Mar 14.

本文引用的文献

1
Understanding cardiovascular disease through the lens of genome-wide association studies.通过全基因组关联研究视角理解心血管疾病
Trends Genet. 2009 Sep;25(9):387-94. doi: 10.1016/j.tig.2009.07.007. Epub 2009 Aug 26.
2
Gene expression profiling in monocytes and SNP association suggest the importance of the STAT1 gene for osteoporosis in both Chinese and Caucasians.单核细胞基因表达谱和 SNP 关联表明 STAT1 基因对中国和高加索人群骨质疏松症的重要性。
J Bone Miner Res. 2010 Feb;25(2):339-55. doi: 10.1359/jbmr.090724.
3
No association between vitamin D receptor polymorphisms and coronary artery disease in a Chinese population.中国人群中维生素D受体基因多态性与冠状动脉疾病无关联。
DNA Cell Biol. 2009 Oct;28(10):521-5. doi: 10.1089/dna.2009.0908.
4
[ARB and anti-aging].
Nihon Rinsho. 2009 Apr;67(4):826-34.
5
Pharmacogenetics of osteoporosis: future perspectives.骨质疏松症的药物遗传学:未来展望。
Calcif Tissue Int. 2009 May;84(5):337-47. doi: 10.1007/s00223-009-9226-x. Epub 2009 Mar 7.
6
Angiotensin II type 2 receptor blockade increases bone mass.血管紧张素II 2型受体阻断可增加骨量。
J Biol Chem. 2009 Feb 20;284(8):4857-64. doi: 10.1074/jbc.M807610200. Epub 2008 Nov 11.
7
Transforming growth factor beta1 T29C gene polymorphism and hypertension: relationship with cardiovascular and renal damage.转化生长因子β1 T29C基因多态性与高血压:与心血管和肾脏损害的关系
Blood Press. 2008;17(4):220-6. doi: 10.1080/08037050802431416.
8
Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: The Cardiovascular Risk in Young Finns Study.白细胞介素6启动子区域的多态性与男性亚临床动脉粥样硬化的危险因素及标志物相关:芬兰青年人心血管风险研究
Atherosclerosis. 2009 Apr;203(2):454-8. doi: 10.1016/j.atherosclerosis.2008.07.014. Epub 2008 Jul 25.
9
Identification of LTBP2 on chromosome 14q as a novel candidate gene for bone mineral density variation and fracture risk association.将14号染色体上的LTBP2鉴定为骨密度变化和骨折风险关联的新型候选基因。
J Clin Endocrinol Metab. 2008 Nov;93(11):4448-55. doi: 10.1210/jc.2007-2836. Epub 2008 Aug 12.
10
Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis.法尼基焦磷酸合酶(FDPS)rs2297480多态性对绝经后骨质疏松症长期氨基双膦酸盐治疗反应的调节作用。
Curr Med Res Opin. 2008 Sep;24(9):2609-15. doi: 10.1185/03007990802352894. Epub 2008 Aug 6.